Trial intelligence / Profile preview

CRFA vs Steroid Injection for Hip OA

NCT04329884Unknown

Sponsor
Brigham and Women's Hospital
Start
Dec 2019
Primary completion
Dec 2021
Countries
1
01

Overview

Randomised, single-blind trial in osteoarthritis (OA) (2 arms), sponsored by Brigham and Women's Hospital. Primary endpoint: Visual Analog Scale Pain at 24 weeks. Status: unknown.

02

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT04329884.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04329884.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call